Evaluation of Clinical Decision Support System for Intracranial Hemorrhage Using Brain CT Images
An Open Label, Single-Center and Random-Selection Retrospective Pivotal Study of Clinical Decision Support System for Intracranial Hemorrhage Using Brain CT Images
1 other identifier
observational
236
1 country
1
Brief Summary
cHS is a software that has been pre-learned based on a intracranial haemorrhage diagnosis model using brain CT images, and clinical decision support system for diagnosing intracranial haemorrhage by automatically analyzing brain CT images by assisting the medical team. The specific aims of this study are to evaluate efficacy of cHS for intracranial haemorrhage compared to the sensitivity and specificity levels of predicate device which is currently approved to triage intracranial haemorrhage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2021
CompletedFirst Submitted
Initial submission to the registry
July 29, 2021
CompletedFirst Posted
Study publicly available on registry
July 30, 2021
CompletedJanuary 14, 2022
January 1, 2022
1 month
July 29, 2021
January 12, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Sensitivity and specificity of cHS
Sensitivity and specificity of cHS in diagnosis of intracranial haemorrhage based on golden standards
Within 4 weeks after collecting data
Study Arms (2)
Abnormal
A patient diagnosed with intracranial haemorrhage after a brain CT scan
Normal
A normal person or a patient not diagnosed with intracranial haemorrhage after a brain CT scan
Interventions
Eligibility Criteria
(1) Adults over 19 years old (2) Brain CT images acquired (3) who confirmed with intracranial haemorrhage(abnormal cohort) or not intracranial haemorrhage or normal(normal cohort)
You may qualify if:
- Adults over 19 years old
- Brain CT acquired
- Abnormal cohort: A patient diagnosed with intracranial haemorrhage after a brain CT scan
- Normal cohort: A normal person or a patient not diagnosed with intracranial haemorrhage after a brain CT scan
You may not qualify if:
- Patients with brain tumor or cerebral toxoplasmosis
- Patients with brain abscess or brain calcification
- Poor or incomplete brain CT image quality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Heuron Inc.lead
Study Sites (1)
Gachon University Gil Medical Center
Incheon, Namdong-gu, 21565, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2021
First Posted
July 30, 2021
Study Start
June 23, 2021
Primary Completion
July 28, 2021
Study Completion
July 28, 2021
Last Updated
January 14, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share